|
AU3213700A
(en)
*
|
1999-01-29 |
2000-08-18 |
Sharper Image Corporation |
A rack for compact discs
|
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
|
US20030175346A1
(en)
*
|
2002-02-01 |
2003-09-18 |
Anne Billotte |
Osmotic delivery system
|
|
US6620900B2
(en)
*
|
2002-02-07 |
2003-09-16 |
Isp Investments Inc. |
Proliferous copolymer of vinyl pyrrolidone and vinyl acetate
|
|
US20070077301A1
(en)
*
|
2002-12-23 |
2007-04-05 |
Meyer Glenn A |
Venlafaxine osmotic device formulation
|
|
US8293799B2
(en)
*
|
2003-12-29 |
2012-10-23 |
Osmotica Keresleedelmo és Szolgáltató KFT |
Osmotic device containing a venlafaxine salt and a salt having an ion in common
|
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
|
WO2006070406A1
(en)
*
|
2004-12-29 |
2006-07-06 |
J.B. Chemicals & Pharmaceuticals Ltd |
Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof
|
|
EP1690540A1
(en)
*
|
2005-02-15 |
2006-08-16 |
Neuro3D |
Composition comprising ocaperidone
|
|
US7405186B2
(en)
|
2005-03-25 |
2008-07-29 |
Chemsil Silicones, Inc. |
Lubricant compositions, condom products and methods of making same
|
|
US8030260B2
(en)
|
2005-03-25 |
2011-10-04 |
Chemsil Silicones, Inc |
Pre-shave compositions and methods of using same
|
|
US20060252745A1
(en)
|
2005-05-06 |
2006-11-09 |
Almeida Jose L D |
Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
|
|
US7855279B2
(en)
*
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
|
JP2009509535A
(ja)
*
|
2005-09-27 |
2009-03-12 |
アムニクス, インコーポレイテッド |
タンパク様薬剤およびその使用
|
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
|
US20070190127A1
(en)
|
2005-12-30 |
2007-08-16 |
Mingdong Zhou |
Extended release of neuregulin for improved cardiac function
|
|
EP2185701A4
(en)
*
|
2007-08-15 |
2011-03-02 |
Amunix Operating Inc |
COMPOSITIONS AND METHODS FOR ENHANCING THE PRODUCTION OF RECOMBINANT POLYPEPTIDES
|
|
US8372431B2
(en)
|
2007-10-26 |
2013-02-12 |
Bial-Portela & C.A., S.A. |
Pharmaceutical composition comprising licarbazepine acetate
|
|
CN102164583B
(zh)
*
|
2008-09-25 |
2013-11-06 |
巴斯夫欧洲公司 |
聚醚基和乙烯基单体基共聚物作为包含固体活性成分的剂型用粘合剂的用途
|
|
US20110046060A1
(en)
|
2009-08-24 |
2011-02-24 |
Amunix Operating, Inc., |
Coagulation factor IX compositions and methods of making and using same
|
|
NZ593833A
(en)
*
|
2009-02-03 |
2013-10-25 |
Amunix Operating Inc |
Extended recombinant polypeptides and compositions comprising same
|
|
WO2010144508A1
(en)
|
2009-06-08 |
2010-12-16 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
|
JP5805634B2
(ja)
|
2009-06-08 |
2015-11-04 |
アムニクス オペレーティング インコーポレイテッド |
成長ホルモンポリペプチド並びにその作成及び使用方法
|
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
|
WO2013054178A2
(en)
|
2011-10-14 |
2013-04-18 |
Micro Labs Limited |
Extended release pharmaceutical compositions containing carmabazepine
|
|
WO2013123457A1
(en)
|
2012-02-15 |
2013-08-22 |
Biogen Idec Ma Inc. |
Recombinant factor viii proteins
|
|
HRP20192314T1
(hr)
|
2012-02-15 |
2020-03-20 |
Bioverativ Therapeutics Inc. |
Pripravci faktora viii i postupci pripreme i njihove uporabe
|
|
CA2879972A1
(en)
|
2012-07-09 |
2014-01-16 |
Fosmo Med, Inc |
Devices using membrane mediated forward osmosis
|
|
US9394327B1
(en)
*
|
2013-03-15 |
2016-07-19 |
The Trustees Of California State University |
Nucleoside crystals, crystal nucleation and growth control with antifreeze proteins
|
|
JP6041823B2
(ja)
|
2013-03-16 |
2016-12-14 |
ファイザー・インク |
トファシチニブの経口持続放出剤形
|
|
EP3033097B1
(en)
|
2013-08-14 |
2021-03-10 |
Bioverativ Therapeutics Inc. |
Factor viii-xten fusions and uses thereof
|
|
CA2994547A1
(en)
|
2015-08-03 |
2017-02-09 |
Bioverativ Therapeutics Inc. |
Factor ix fusion proteins and methods of making and using same
|
|
US12433850B2
(en)
|
2016-05-05 |
2025-10-07 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine and prodrug compositions
|
|
US12427121B2
(en)
|
2016-05-05 |
2025-09-30 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine compositions
|
|
KR20190005199A
(ko)
|
2016-05-05 |
2019-01-15 |
어퀘스티브 테라퓨틱스, 아이엔씨. |
강화된 전달 에프네프린 조성물
|
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
|
BR112019011115A2
(pt)
|
2016-12-02 |
2019-10-01 |
Bioverativ Therapeutics Inc |
métodos para tratar artropatia hemofílica usando fatores de coagulação quiméricos
|
|
CN108125922A
(zh)
*
|
2018-01-14 |
2018-06-08 |
上海安必生制药技术有限公司 |
一种卡马西平口服缓释制剂及其制备方法
|
|
DK3793588T3
(da)
|
2018-05-18 |
2025-06-16 |
Bioverativ Therapeutics Inc |
Fremgangsmåder til behandling af hæmofili a
|
|
KR20230041711A
(ko)
|
2020-06-25 |
2023-03-24 |
아뮤닉스 파마슈티컬스, 인크. |
Her-2 표적화 이중특이적 조성물 및 이의 제조 및 사용 방법
|